MRNA240712C114000
- 3.55
- -1.05-22.83%
Moderna Newsroom
Moderna in Joint Deal to Commercialize Covid-19 Vaccine in Japan
By Sabela Ojea Moderna has signed a deal with Japan-based Mitsubishi Tanabe Pharma to handle the manufacturing, sales and distribution of its Covid-19 Spikevax vaccine and other mRNA respiratory vacci
Reported Earlier, Moderna And Mitsubishi Tanabe Pharma Partner To Promote MRNA Respiratory Vaccine Portfolio In Japan
Under the agreement, Moderna will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory vaccines. Both companies will engage in activities to enable broad access
Express News | Moderna :Co & Mitsubishi Tanabe Pharma Enter Joint Agreement to Promote Co’s Mrna Respiratory Vaccine Portfolio in Japan, Including Covid-19 Vaccines
Unpacking the Latest Options Trading Trends in Moderna
Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available options
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Signs are emerging that the market boom surrounding artificial intelligence (AI) might be taking on the characteristics of a bubble.
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 37.68% on an annualized basis producing an average annual return of 50.84%. Currently, Moderna has a market capitalization of
Moderna Given $176 Million to Advance Bird Flu Vaccine
A Fourth Dairy Worker Tests Positive for Bird Flu as Federal Response Ramps Up -- Barrons.com
By Josh Nathan-Kazis A Colorado dairy worker has tested positive for avian influenza, the Centers for Disease Control and Prevention said Wednesday afternoon, bringing the total number of farmers inf
What's Going On With Moderna Stock Wednesday
Moderna, Inc. (NASDAQ:MRNA) shares are trending on Wednesday.
GSK Will Pay Up to $1.5 Billion for CureVac's MRNA Vaccines -- Barrons.com
By Josh Nathan-Kazis The drugmaker GSK plunged into the messenger RNA-based vaccine market Wednesday, announcing it will buy the rights to experimental influenza and Covid-19 mRNA vaccines from the b
Moderna Stock (NASDAQ:MRNA): Next-Gen COVID-19 Vaccine Is More Than a Rehash
MRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens
COVID Infections Could Be Seeing a Summer Surge Based on CDC Data
US HHS Says 8 Labs Sign Royalty-Free Agreements For H5N1 Tests
US HHS Says 8 Labs Sign Royalty-Free Agreements For H5N1 Tests; Moderna Deal Allows Pivot To Other Pandemic Threats; Too Early To Determine Moderna Vaccine Production Capacity; First H5N1 Vaccines Fro
Express News | US Cdc Official Says There Are 750,000 H5N1 Tests Available and 1.2 Million Tests Coming Online in the Next Two to Three Months
Express News | US Hhs Official Says Risk of Bird Flu Remains Low, and Vaccination Is Not Recommended for Any Segment of the Population
Express News | US Cdc Official Said the Agency Says Agency Has Been Working With Commercial Testing Labs; 8 Have Already Signed Royalty Free Agreements to Make H5N1 Tests
Express News | US FDA Says Lab Experiments Confirm That Pasteurization Inactivates Milk Tainted With H5N1 Virus
Express News | US Hhs Says Moderna Late Stage Trials of H5N1 Will Likely Start in 2025
Express News | US Hhs Official Says It Is Too Early to Tell How Many Doses Moderna Would Be Able to Manufacture